BioForm Announces Financial Results for Quarter Ended December 31, 2007, Second Quarter of F...(naudited) (in thousan...),Health

(in thousands, except per share data)

Three months ended Six months ended

December 31, December 31,

2007 2006 2007 2006

Net sales $ 18,616 $ 11,836 $ 33,817 $ 19,626

Cost of sales 3,080 2,244 5,872 3,803

Gross profit 15,536 9,592 27,945 15,823

Operating expenses:

Sales and marketing 13,109 8,935 24,863 15,388

Research and development 2,183 1,600 4,364 2,621

General and

administrative 2,220 2,017 4,244 3,338

Total operating expenses 17,512 12,552 33,471 21,347

Other income (expenses),

net

Interest income, net 587 228 748 482

Other income

(expenses), net (132) 51 (101) 39

Loss before income taxes (1,521) (2,681) (4,879) (5,003)

Provision for income taxes 83 55 141 75

Net loss attributable to

common stockholders $ (1,604) $ (2,736) $ (5,020) $ (5,078)

Net loss per common share,

basic and diluted $ (0.06) $ (0.73) $ (0.30) $ (1.41)

Weighted-average number

of shares used in per

share calculation,

basic and diluted 28,777 3,734 16,472 3,598

BioForm Medical, Inc.

Condensed Consolidated Balance Sheets

December June 30,

31, 2007 2007

ASSETS
'/>"/>